Login / Signup

Ruxolitinib: a new first-line strategy in autoimmune myelofibrosis treatment.

Domenico PennaAlessia TieghiRiccardo ValliFrancesco Merli
Published in: Leukemia & lymphoma (2023)
Keyphrases
  • multiple sclerosis
  • replacement therapy